Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Colonic Neoplasms × Fatty Acids, Omega-3 × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Carcinoma, Intraductal, Noninfiltrating 2 Smoldering Multiple Myeloma 1 Polyps 1 Peripheral Nervous System Diseases 1 Monoclonal Gammopathy of Undetermined Significance 1 Malnutrition 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Dyspareunia 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms, Male 1 Breast Carcinoma In Situ 1

Interventions

Fluorouracil 80 Oxaliplatin 73 Leucovorin 73 Irinotecan 68 Bevacizumab 45 Capecitabine 39 Cetuximab 36 Panitumumab 15 Folfox protocol 15 Floxuridine 11 Chemotherapy, Adjuvant 11 IFL protocol 9 Surgical Procedures, Operative 8 Neoadjuvant Therapy 8 Drug Therapy 8 trifluridine tipiracil drug combination 7 regorafenib 7 pembrolizumab 7 XELOX 7 Nivolumab 7 Radiotherapy 6 sargramostim 5 Trastuzumab 5 Melphalan 5 Immunohistochemistry 5 Dexamethasone 5 Celecoxib 5 Biopsy 5 tislelizumab 4 aflibercept 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03661047 2021-11-17

OMICC

Massachusetts General Hospital

Phase 2 Withdrawn

Gastrointestinal

Colonic Neoplasms, Polyps, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡